Development and validation of the Nightingale Symptom Assessment Scale (N-SAS) and predictors of the quality of life of the cancer patients in Turkey

2011 ◽  
Vol 15 (1) ◽  
pp. 3-11 ◽  
Author(s):  
Gulbeyaz Can ◽  
Adnan Aydiner
Keyword(s):  
Quality Of Life ◽  
Cancer Patients ◽  
Symptom Assessment ◽  
Assessment Scale ◽  
Symptom Assessment Scale ◽  
Development And Validation

Implementation of the VA Symptom Assessment Scale (VSAS): Five-year experience.

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e23120-e23120
Author(s):  
Daphne Ruth Friedman ◽  
Vikas Patil ◽  
Kelli Marie Rasmussen ◽  
Brian C Sauer ◽  
Michael J. Kelley ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Cancer Patients ◽  
Symptom Assessment ◽  
Assessment Scale ◽  
Veterans Health ◽  
Health Administration ◽  
Clinical Tool ◽  
Patient Reported ◽  
Symptom Assessment Scale

e23120 Background: Cancer patients experience symptoms which may precede diagnosis, occur during therapy, and persist into survivorship. Symptom assessments and patient reported outcomes have been shown to improve quality of life and extend survival in cancer patients. The Veterans Administration Symptom Assessment Scale (VSAS) is a clinical tool to document cancer-related symptoms. Here, we report VSAS adoption in five Veterans Health Administration (VHA) hematology-oncology sites during a five-year period. Methods: Data was collected from the Corporate Data Warehouse (CDW): VSAS data, date of birth, gender, race, ethnicity, vital status, year of cancer diagnosis, ICD-O-3, VHA facility, and clinic stop codes. Descriptive analyses of patient demographics, disease characteristics, and VSAS utilization was performed. VSAS is comprised of 13 symptoms, rated on a 0 to 10 scale. A VSAS visit was defined as the date the VSAS was administered to a patient. Results: From January 2013 through June 2018, there were 41,917 instances of VSAS administered to 9,409 unique patients at five VHA facilities: 8,512 (90.5%) were male; 5,241 (56%) were non-Hispanic White, 3,743 (40%) were Black, and 297 (3%) were other racial categories or not available. The median age at the first VSAS visit was 67 years. In patients whose oncologic diagnosis was recorded by a cancer registrar (4,536), the most common diagnoses were prostate cancer, lung cancer (all histologies), colon cancer, and multiple myeloma. The number of VSAS administrations increased annually, from 866 in 2013 to 12,775 in 2017, which may be attributed to increased adoption of VSAS across and within VHA facilities. Individual patients completed the VSAS 1-57 times (median 2). At the five VHA facilities utilizing VSAS in 2017, VSAS was administered at 56% of hematology-oncology clinic visits. Conclusions: VSAS is a tool to measure and document patient symptom burden, and has been successfully adopted in the last five years at select VHA facilities. Expanded use of VSAS throughout the VHA is an important step in improving the quality of life and extending survival of veterans with cancer and blood disorders.

Equivalência semântica da versão em português do instrumento Memorial Symptom Assessment Scale (MSAS) para avaliar sintomas em pacientes oncológicos

1969 ◽  
Vol 19 (2) ◽  
pp. 83-91 ◽  
Author(s):  
Larissa Fernandes Da Rocha ◽  
Monique da Silva Carvalho ◽  
Ana Amélia Moraes de Lacerda ◽  
Áila Ferreira Vizeu Viana ◽  
Raquel de Souza Ramos ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Symptom Assessment ◽  
Assessment Scale ◽  
Semantic Equivalence ◽  
Portuguese Version ◽  
Memorial Symptom Assessment Scale ◽  
Symptom Assessment Scale

Semantic equivalence of the Portuguese version ofthe Memorial Symptom Assessment Scale (MSAS) to evaluate symptoms in cancer patients

Development and Validation of a Modified Version of the Edmonton Symptom Assessment Scale in a Flemish Palliative Care Population

2011 ◽  
Vol 28 (7) ◽  
pp. 475-482 ◽  
Author(s):  
Patricia Claessens ◽  
Johan Menten ◽  
Paul Schotsmans ◽  
Bert Broeckaert
Keyword(s):  
Palliative Care ◽  
Symptom Assessment ◽  
Assessment Scale ◽  
Face Validity ◽  
Patients With Cancer ◽  
Edmonton Symptom Assessment Scale ◽  
The Face ◽  
Palliative Care Units ◽  
Symptom Assessment Scale ◽  
Development And Validation

Palliative cancer patients are faced with multiple symptoms that threaten their quality of life. To manage these symptoms, a reliable and valid way of registration is crucial. In this study, the Edmonton Symptom Assessment Scale (ESAS) has been translated, modified, and tested on content, face, criterion, construct validity, and internal consistency for patients admitted to Flemish palliative care units. These aspects are tested in a descriptive, comparative, longitudinal study based on 3 convenience samples. The first consisted of 8 palliative care experts. The second sample checked the face validity and consisted of 4 patients, 5 family members, and 5 nurses. The last sample involved 23 patients admitted to 3 Flemish palliative care units. Heedful of the “new-wave” vision on validity, the translated and altered ESAS seemed a suitable instrument for the symptom assessment of patients with cancer admitted to a palliative care unit.

Sign in / Sign up

Export Citation Format

Share Document